Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD

Nanomedicine: Nanotechnology, Biology and Medicine · Elsevier

Аннотация

Publication date: December 2026 Source: Nanomedicine: Nanotechnology, Biology and Medicine, Volume 78 Author(s): Yuqing Shen, Xuan Cai, Huaijun Zheng, Zetong Zheng, Li Wu, Meng Yuan, Xi Jin, Dan Ye, Ye Feng

Читать у издателя →

Похожие статьи